Longterm effects of hepatic arterial interleukin-2-based immunochemotherapy after potentially curative resection of colorectal liver metastases

Journal of the American College of Surgeons

Volumn 187, Issue 3, 1998, Pages 271-275

  Okuno, Kiyotaka ^a   Yasutomi, Masayuki ^a   Hida, Jin Ichi ^a   Kayama, Hitoshi ^a   Nakai, Takuya ^a   Funai, Sadao ^a   Koh, Kenzo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; FEVER; GASTRITIS; HEPATIC ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PEPTIC ULCER; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTERLEUKIN-2; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PILOT PROJECTS; SURVIVAL RATE;

EID: 0031694710     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00157-4     Document Type: Article

References (15)

1. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988;103:278-288.
2. Fortner JG, Silva JS, Golbey RB, et al. Multi-variate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 1984;199:306-316.
3. Rosen C, Donohue JH, Nagorney DM. Liver resection for metastatic colonic and rectal carcinoma. In: Cohen AM, and Winawer SJ, eds. Cancer of the Colon, Rectum, and Anus. New York: McGraw-Hill; 1995:805-821.
4. Curley SA, Roh MS, Chase JL, et al. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 1993;166:743-748.
5. Kemeny NE, Seiter K. Hepatic arterial chemotherapy. In: Cohen AM, and Winawer SJ, eds. Cancer of the Colon, Rectum, and Anus. New York: McGraw-Hill; 1995;831-843.
6. Kemeny NE. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! In: DeVita VT Jr, Hellman S, and Rosenberg S, eds. Important Advances in Oncology. Philadelphia: JB Lippincott; 1992:207-227.
7. O'Connell MJ. Is hepatic infusion of chemotherapy effective treatment for liver metastases? No! In: DeVita VT Jr, Hellman S, and Rosenberg S, eds. Important Advances in Oncology. Philadelphia: JB Lippincott; 1992:229-234.
8. Okuno K, Hirohata T, Nakamura K, et al. Hepatic arterial infusions of interleukin-2 (IL-2)-based immunochemotherapy in the treatment of unresectable liver metastases from colorectal cancer. Clin Ther 1993;15:672-683.
9. Okuno K, Yasutomi M. Locoregional immuno-chemotherapy in liver carcinoma - present and future. Hepatogastroenterology 1995;42:578-586.
10. Bouwens L, Jacobs R, Remels L, et al. Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol Immunother 1988;27: 137-141.
11. Takagi S, Chen K, Schwarz, et al. Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2. Cancer 1989;63:102-111.
12. Mihich E, Ehrke M. Immunomodulation by anticancer drugs. In: DeVita VT Jr, Hellman S, and Rosenberg S, eds. Biologic Therapy of Cancer. Philadelphia: JB Lippincott; 1991:776-786.
13. Kreuser ED, Wadler S, Thiel E. Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and oncology. Semin Oncol 1992;19:1-7.
14. Chu E, Zinn S, Boarman D, et al. Interaction of γ-interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 1990;50:5834-5840.
15. Okuno K, Kobayashi S, Jinnai H, et al. IL-2 perfusion to the liver augments the hepatic extraction rate of accompanying anti-cancer drugs. Surg Today 1996;26:662-664.